Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma

World Journal of Surgical Oncology

Zongyou Chen²  Chao Lu¹  Luchun Hua²  Yaping Wang² 

[1] Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China;Department of Surgery, Huashan Hospital, Fudan University, Shanghai, China

关键词: expression;    colorectal carcinoma;    human Period2 (hPer2);    clock gene;    circadian;   

Others  :  1206586
DOI  :  10.1186/1477-7819-9-166

 received in 2011-09-08, accepted in 2011-12-13,  发布年份 2011

【 摘 要 】

Background

Recent studies have shown that disruption of circadian rhythms is one of the tumor promoting factors which contribute to mammalian cancer development and progression, but very little is known about the molecular changes of circadian genes in colorectal carcinoma (CRC). Thus, in this study, changes in the expression of human Period2 (hPer2), one of the key circadian clock regulators, in CRC and its correlation with prognosis were investigated.

Methods

Immunohistochemical (IHC) staining and real-time PCR for hPer2 were performed for 38 CRC cases.

Results

IHC analysis detected positive staining for hPer2 in 81.6% (31/38) of CRC tissues and 97.4% (37/38) of surrounding non-cancerous tissues (P < 0.05). Most colorectal cells in non-cancerous tissues were homogeneously stained. In contrast, in the paired cancerous tissues, a heterogeneous pattern was found with a significant portion of cancer cells displaying negative or weak hPer2 staining. In over 60% cases (24/38), the staining for hPer2 was much stronger in non-cancerous cells than in the paired cancerous cells. Well-differentiated cancer cells are more likely to maintain hPer2 expression than poorly-differentiated ones. Furthermore, associations of decreased hPer2 levels with patients' age, histological grade, TNM stage and expression of nucleus proliferation related antigen: Ki67 were also detected (P < 0.05). Expression of hPer2 did not correlate with that of either p53 or C-erB-2. Similar to hPer2 protein expression, quantitative RT-PCR for hPer2 also showed decreased mRNA expression in CRC.

Conclusion

These results suggest a role for hPer2 in normal colorectal cell function and the potential deregulation of hPer2 expression in the development, invasion, and metastasis of CRC.

【 授权许可】

   
2011 Wang et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Gery S, Koeffler HP: The Role of Circadian Regulation in Cancer. [J] Cold Spring Harb Symp Quant Biol 2007, 72:459-464.
• [2]Misty CG, Cheng CL, Lee CC: Tumor Suppression and Circadian Function. [J] Journal of Biological Rhythms 2007, 22(4):291-298.
• [3]Ko CH, Takahashi JS: Molecular components of the mammalian circadian clock. [J] Hum Mol Genet 2006, 15(2):R271-277.
• [4]Koyomi M, Miyuki W, Yasuhiro H, Ishida N: Tumor growth suppression in vivo by overexpression of the circadian component, PER2. [J] Genes to Cells 2010, 15(4):351-358.
• [5]Yang XM, Wood PA, Ansell C, Hrushesky WJM: Circadian time-dependent tumor suppressor function of Period genes. [J] Integrative Cancer Therapies 2009, 8(4):309-316.
• [6]Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG: Deregulated expression of the PER1, PER2 and PER3 gene in breast cancer. [J] Oxford University Press 2005, 26(7):1241-1246.
• [7]Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP: Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. [J] Blood 2005, 106(8):2827-2836.
• [8]Laurence C, Tomoko K, Vincent L: The days and Nights of cancer cells. [J] Cancer Research 2003, 63(22):7545-7552.
• [9]Filipski E: Host circadian clock as a control point in tumour progression. [J] Natl Cancer Inst 2002, 94(9):690-697.
• [10]Fu L, Pelicano H, Liu JS, Huang P, Lee CC: The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo. [J] Cell 2002, 111(1):41-50.
• [11]Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP: The clock gene Per2 links the circadian system to the estrogen receptor. [J] Oncogene 2007, 26(57):7916-7920.
• [12]Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang Z, Ding JM: Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. [J] Cancer Gene Ther 2007, 14(9):815-818.
• [13]Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F: Circadian gene mPer2 overexpression induces cancer cell apoptosis. [J] Cancer Sci 2006, 97(7):589-596.
• [14]Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y: Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. [J] Am J Pathol 2001, 158(5):1793-1801.
• [15]Orr MS, O'Connor PM, Kohn KW: Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells. [J] Natl Cancer Inst 2000, 92(12):987-994.
• [16]Karnes WJ, Weller SG, Adjei PN, Kottke TJ, Glenn KS, Gores GJ, Kaufmann SH: Inhibition of epidermal growth factor receptor kinase induces proteasedependent apoptosis in human colon cancer cells. [J] Gastroenterology 1998, 114(5):930-939.
• [17]Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. [J] Nature 2000, 408(6810):307-310.
• [18]Rebecca S, Ahmedin J: Colorectal Cancer Facts and Figures. [http:/ / www.cancer.org/ Research/ CancerFactsFigures/ ColorectalCancerFactsFigures] webciteAmerican Cancer Society (ACS), Atlanta, Georgia; 2011.
• [19]Zheng S, Cai SR: Colorectal cancer epidemiology and prevention study in China. [J] The Chinese-German journal of clinical oncology 2003, 2(2):72-75.
• [20]Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, Liu X, Atwood A, Huss JW, Janes J, Su A, Hogenesch JB, Kay SA: A Genome-wide RNAi screen for modifiers of the circadian clock in human cells. [J] Cell 2009, 139(1):199-210.
• [21]Scheving LA: Biological clocks and the digestive system. [J] Gastroenterology 2000, 119(2):536-549.
• [22]Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Lacobelli S, Genet D, Tampellini M, Chollet P, Lentz MA, Mormont MC, Levi F, Bjarnason GA: Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. [J] Cancer Res 2009, 69(11):4700-4707.
• [23]Keith I, Penny B, Susan R, Jamie S, April Y, Michael D, Deva N, Peter T, Amanda K, Charlotte G: Making circadian cancer therapy Practical. [J] Integr Cancer Ther 2009, 8(4):371-386.
• [24]Giachetti S, Perpoint B, Zidani R, Bail L, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Rol AL, Walter S, Adam R, Misset JL, Levi F: Phase III multicenter randomized trail of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. [J] J Clin Oncol 2002, 18(1):136-147.
• [25]Sylvie G: Chronotherapy of colorectal cancer. [J] Chronobiology International 2002, 19(1):207-219.
• [26]Yang XM, Wood PA, Oh EY, Du-Qution J, Ansell CM, Hrushesky WJM: Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. [J] Breast Cancer Res Treat 2009, 117(2):423-431.
• [27]Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC, Lin SF, Su WW, Chang JG: Disturbance of circadian gene expression in hepatocellular carcinoma. [J] Molecular Carcinogenesis 2008, 47(12):925-933.
• [28]Lee CC: Tumor suppression by the mammalian Period genes. [J] Cancer Causes Control 2006, 17(4):525-530.
• [29]Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH: An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. [J] Science 2001, 291(5506):1040-1043.
• [30]Reppert SM, Weaver DR: Coordination of circadian timing in mammals. [J] Nature 2002, 418(6901):935-941.
• [31]Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR: Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. [J] Neuron 2001, 3(2):525-536.
• [32]Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, Lee CC: Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. [J] Cell 2001, 105(5):683-694.
• [33]Zheng Binhai Larkin, David W, Albrecht Urs, Sun Zhong Sheng, Sage Marijke, Eichele Gregor, Lee Cheng Chi, Bradley Allan: The mPer2 gene encodes a functional component of the mammalian circadian clock. [J] Nature 1999, 400(6740):169-173.
• [34]Yeh KT, Yang MY, Liu TC, Chen JC, Chan WL, Lin SF, Chang JG: Abnormal expression of period 1 (PER1) in endometrial carcinoma. [J] J Pathol 2005, 206(1):111-120.
• [35]Remco N, Linda C, Reuven A: The miRNA-192⁄194 cluster regulates the Period gene family and the circadian clock. [J] FEBS Journal 2009, 276(19):5447-5455.